Cargando…
The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders
BACKGROUND: There is often a discordance between health research evidence and public health policies implemented by the United States federal government. In the process of developing health policy, discordance can arise through subjective and objective factors that are unrelated to the value of the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097290/ https://www.ncbi.nlm.nih.gov/pubmed/30115085 http://dx.doi.org/10.1186/s12961-018-0336-7 |
_version_ | 1783348272025305088 |
---|---|
author | Malekinejad, Mohsen Horvath, Hacsi Snyder, Harry Brindis, Claire D. |
author_facet | Malekinejad, Mohsen Horvath, Hacsi Snyder, Harry Brindis, Claire D. |
author_sort | Malekinejad, Mohsen |
collection | PubMed |
description | BACKGROUND: There is often a discordance between health research evidence and public health policies implemented by the United States federal government. In the process of developing health policy, discordance can arise through subjective and objective factors that are unrelated to the value of the evidence itself, and can inhibit the use of research evidence. We explore two common types of discordance through four illustrative examples and then propose a potential means of addressing discordance. DISCUSSION: In Discordance 1, public health authorities make recommendations for policy action, yet these are not based on high quality, rigorously synthesised research evidence. In Discordance 2, evidence-based public health recommendations are ignored or discounted in developing United States federal government policy. Both types could lead to serious risks of public health and clinical patient harms. We suggest that, to mitigate risks associated with these discordances, public health practitioners, health policy-makers, health advocates and other key stakeholders should take the opportunity to learn or expand their knowledge regarding current research methods, as well as improve their skills for appropriately considering the strengths and limitations of research evidence. This could help stakeholders to adopt a more nuanced approach to developing health policy. Stakeholders should also have a more insightful contextual awareness of these discordances and understand their potential harms. In Discordance 1, public health organisations and authorities need to acknowledge their own historical roles in making public health recommendations with insufficient evidence for improving health outcomes. In Discordance 2, policy-makers should recognise the larger impact of their decision-making based on minimal or flawed evidence, including the potential for poor health outcomes at population level and the waste of huge sums. In both types of discordance, stakeholders need to consider the impact of their own unconscious biases in championing evidence that may not be valid or conclusive. CONCLUSION: Public health policy needs to provide evidence-based solutions to public health problems, but this is not always done. We discuss some of the factors inhibiting evidence-based decision-making in United States federal government public health policy and suggest ways these could be addressed. |
format | Online Article Text |
id | pubmed-6097290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60972902018-08-20 The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders Malekinejad, Mohsen Horvath, Hacsi Snyder, Harry Brindis, Claire D. Health Res Policy Syst Opinion BACKGROUND: There is often a discordance between health research evidence and public health policies implemented by the United States federal government. In the process of developing health policy, discordance can arise through subjective and objective factors that are unrelated to the value of the evidence itself, and can inhibit the use of research evidence. We explore two common types of discordance through four illustrative examples and then propose a potential means of addressing discordance. DISCUSSION: In Discordance 1, public health authorities make recommendations for policy action, yet these are not based on high quality, rigorously synthesised research evidence. In Discordance 2, evidence-based public health recommendations are ignored or discounted in developing United States federal government policy. Both types could lead to serious risks of public health and clinical patient harms. We suggest that, to mitigate risks associated with these discordances, public health practitioners, health policy-makers, health advocates and other key stakeholders should take the opportunity to learn or expand their knowledge regarding current research methods, as well as improve their skills for appropriately considering the strengths and limitations of research evidence. This could help stakeholders to adopt a more nuanced approach to developing health policy. Stakeholders should also have a more insightful contextual awareness of these discordances and understand their potential harms. In Discordance 1, public health organisations and authorities need to acknowledge their own historical roles in making public health recommendations with insufficient evidence for improving health outcomes. In Discordance 2, policy-makers should recognise the larger impact of their decision-making based on minimal or flawed evidence, including the potential for poor health outcomes at population level and the waste of huge sums. In both types of discordance, stakeholders need to consider the impact of their own unconscious biases in championing evidence that may not be valid or conclusive. CONCLUSION: Public health policy needs to provide evidence-based solutions to public health problems, but this is not always done. We discuss some of the factors inhibiting evidence-based decision-making in United States federal government public health policy and suggest ways these could be addressed. BioMed Central 2018-08-16 /pmc/articles/PMC6097290/ /pubmed/30115085 http://dx.doi.org/10.1186/s12961-018-0336-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Opinion Malekinejad, Mohsen Horvath, Hacsi Snyder, Harry Brindis, Claire D. The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders |
title | The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders |
title_full | The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders |
title_fullStr | The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders |
title_full_unstemmed | The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders |
title_short | The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders |
title_sort | discordance between evidence and health policy in the united states: the science of translational research and the critical role of diverse stakeholders |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097290/ https://www.ncbi.nlm.nih.gov/pubmed/30115085 http://dx.doi.org/10.1186/s12961-018-0336-7 |
work_keys_str_mv | AT malekinejadmohsen thediscordancebetweenevidenceandhealthpolicyintheunitedstatesthescienceoftranslationalresearchandthecriticalroleofdiversestakeholders AT horvathhacsi thediscordancebetweenevidenceandhealthpolicyintheunitedstatesthescienceoftranslationalresearchandthecriticalroleofdiversestakeholders AT snyderharry thediscordancebetweenevidenceandhealthpolicyintheunitedstatesthescienceoftranslationalresearchandthecriticalroleofdiversestakeholders AT brindisclaired thediscordancebetweenevidenceandhealthpolicyintheunitedstatesthescienceoftranslationalresearchandthecriticalroleofdiversestakeholders AT malekinejadmohsen discordancebetweenevidenceandhealthpolicyintheunitedstatesthescienceoftranslationalresearchandthecriticalroleofdiversestakeholders AT horvathhacsi discordancebetweenevidenceandhealthpolicyintheunitedstatesthescienceoftranslationalresearchandthecriticalroleofdiversestakeholders AT snyderharry discordancebetweenevidenceandhealthpolicyintheunitedstatesthescienceoftranslationalresearchandthecriticalroleofdiversestakeholders AT brindisclaired discordancebetweenevidenceandhealthpolicyintheunitedstatesthescienceoftranslationalresearchandthecriticalroleofdiversestakeholders |